13F

Stock

Vanda Pharmaceuticals Inc.

VNDA · held by 2 managers

Reported value

$794.9K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$26.9K

Price effect on 1 books still in the name

Largest holder

$714.9K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC96.7K$714.9KHeld
Henshaw Capital LLC10.8K$80K−$26.9KCut−$26.9K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.